Liver diseases are the fourth leading cause of mortality among adults in the United States. Patients with chronic liver diseases such as viral hepatitis, fibrosis, and cirrhosis have significantly higher risks of developing hepatocellular carcinoma (HCC). With a dismal five-year survival rate of 11%, HCC is the third most common cause of cancer-related deaths worldwide. Regardless of the underlying cause, late presentation and a lack of effective therapy are the major impediments for successful treatment of HCC. Therefore, there is a considerable interest in developing new strategies for the prevention and treatment of chronic liver diseases at the early stages. Cancer stem cells (CSCs), a small cell subpopulation in a tumor, exhibit unlimited self-renewal and differentiation capacity. These cells are believed to play pivotal roles in the initiation, growth, metastasis, and drug-resistance of tumors. In this review, we will briefly discuss pivotal roles of the CSC marker doublecortin-like kinase 1 (DCLK1) in hepatic tumorigenesis. Recent evidence suggests that anti-DCLK1 strategies hold promising clinical potential for the treatment of cancers of the liver, pancreas, and colon.
MokdadAALopezADShahrazSLozanoRMokdadAHStanawayJMurrayCJNaghaviM. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med2014; 12: 145–145.
2.
WangFSFanJGZhangZGaoBWangHY. The global burden of liver disease: the major impact of China. Hepatology2014; 60: 2099–108.
3.
YangJDRobertsLR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol2010; 7: 448–58.
4.
FerlayJShinHRBrayFFormanDMathersCParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer2010; 127: 2893–917.
5.
JemalASiegelRWardEHaoYXuJThunMJ. Cancer statistics, 2009. CA Cancer J Clin2009; 59: 225–49.
6.
MittalSEl-SeragHB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol2013; 47: S2–6.
7.
El-SeragHB. Hepatocellular carcinoma. N Engl J Med2011; 365: 1118–27.
8.
BertinoGDemmaSArdiriAProitiMGruttadauriaSToroAMalaguarneraGBertinoNMalaguarneraMMalaguarneraMDi CarloI. Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies. Biomed Res Int2014. 2014:203693.
9.
SingalAGPillaiATiroJ. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med2014; 11: e1001624–e1001624.
10.
PadhyaKTMarreroJASingalAG. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol2013; 29: 285–92.
11.
LlovetJMRicciSMazzaferroVHilgardPGaneEBlancJFde OliveiraACSantoroARaoulJLFornerASchwartzMPortaCZeuzemSBolondiLGretenTFGallePRSeitzJFBorbathIHaussingerDGiannarisTShanMMoscoviciMVoliotisDBruixJGroupSIS. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med2008; 359: 378–90.
12.
GauthierAHoM. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: an update. Hepatol Res2013; 43: 147–54.
13.
ChowAKNgLLamCSWongSKWanTMChengNSYauTCPoonRTPangRW. The enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance. PLoS One2013; 8: e78675–e78675.
14.
KasaiTChenLMizutaniAKudohTMurakamiHFuLSenoM. Cancer stem cells converted from pluripotent stem cells and the cancerous niche. J Stem Cells Regen Med2014; 10: 2–7.
15.
FindlayVJWangCWatsonDKCampER. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer. Cancer Gene Ther2014; 21: 181–7.
16.
KwonYCBoseSKSteeleRMeyerKDi BisceglieAMRayRBRayR. Promotion of cancer stem-like cell properties in hepatitis C virus-infected hepatocytes. J Virol2015; 89: 11549–56.
17.
FeldmanDEChenCPunjVTsukamotoHMachidaK. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proc Natl Acad Sci U S A2012; 109: 829–34.
18.
KimMHCierpickiTDerewendaUKrowarschDFengYDevedjievYDauterZWalshCAOtlewskiJBushwellerJHDerewendaZS. The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nat Struct Biol2003; 10: 324–33.
19.
BurgessHAReinerO. Alternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activities. J Biol Chem2002; 277: 17696–705.
20.
LinPTGleesonJGCorboJCFlanaganLWalshCA. DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci2000; 20: 9152–61.
21.
BiasiniMBienertSWaterhouseAArnoldKStuderGSchmidtTKieferFGallo CassarinoTBertoniMBordoliLSchwedeT. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res2014; 42: W252–8.
22.
O’ConnellMRSarkarSLuthraGKOkugawaYToiyamaYGajjarAHQiuSGoelASinghP. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: clinical implications. Sci Rep2015; 5: 14983–14983.
23.
BurgessHAReinerO. Cleavage of doublecortin-like kinase by calpain releases an active kinase fragment from a microtubule anchorage domain. J Biol Chem2001; 276: 36397–403.
24.
EngelsBMSchoutenTGvan DullemenJGosensIVreugdenhilE. Functional differences between two DCLK splice variants. Brain Res Mol Brain Res2004; 120: 103–14.
25.
Sossey-AlaouiKSrivastavaAK. DCAMKL1, a brain-specific transmembrane protein on 13q12.3 that is similar to doublecortin (DCX). Genomics1999; 56: 121–6.
LipkaJKapiteinLCJaworskiJHoogenraadCC. Microtubule-binding protein doublecortin-like kinase 1 (DCLK1) guides kinesin-3-mediated cargo transport to dendrites. EMBO J2016; 35: 302–18.
28.
AliNAllamHMayRSurebanSMBronzeMSBaderTUmarSAnantSHouchenCW. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol2011; 85: 12292–303.
29.
MayRRiehlTEHuntCSurebanSMAnantSHouchenCW. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells2008; 26: 630–7.
30.
MayRSurebanSMLightfootSAHoskinsABBrackettDJPostierRGRamanujamRRaoCVWycheJHAnantSHouchenCW. Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. Am J Physiol Gastrointest Liver Physiol2010; 299: G303–10.
31.
VegaKJMayRSurebanSMLightfootSAQuDReedAWeygantNRamanujamRSouzaRMadhounMWhortonJAnantSMeltzerSJHouchenCW. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett’s esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol2012; 27: 773–80.
32.
NakanishiYSenoHFukuokaAUeoTYamagaYMarunoTNakanishiNKandaKKomekadoHKawadaMIsomuraAKawadaKSakaiYYanagitaMKageyamaRKawaguchiYTaketoMMYoneharaSChibaT. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet2013; 45: 98–103.
33.
AliNChandrakesanPNguyenCBHusainSGillaspyAFHuyckeMBerryWLMayRQuDWeygantNSurebanSMBronzeMSDhanasekaranDNHouchenCW. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget2015; 6: 20327–44.
34.
QuDMayRSurebanSMWeygantNChandrakesanPAliNLiLBarrettTHouchenCW. Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt epithelial stem cells following radiation injury. Am J Physiol Gastrointest Liver Physiol2014; 306: G404–11.
35.
LaiCKJengKSMachidaKLaiMM. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol2008; 82: 8838–48.
36.
CounihanNARawlinsonSMLindenbachBD. Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog2011; 7: e1002302–e1002302.
37.
RyckmanCVandalKRouleauPTalbotMTessierPA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol2003; 170: 3233–42.
38.
SrikrishnaG. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun2012; 4: 31–40.
39.
VoglTLudwigSGoebelerMStreyAThoreyISReicheltRFoellDGerkeVManitzMPNackenWWernerSSorgCRothJ. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood2004; 104: 4260–8.
40.
GoyetteJGeczyCL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids2011; 41: 821–42.
41.
MehtaARArmstrongAJ. Tasquinimod in the treatment of castrate-resistant prostate cancer – current status and future prospects. Ther Adv Urol2016; 8: 9–18.
42.
InokuchiMItoTUchikoshiMShimozumaYMorikawaKNozawaHShimazakiTHiroishiKMiyakawaYImawariM. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C. J Med Virol2009; 81: 619–27.
43.
IdilmanRColantoniADe MariaNAlkanSNandSVan ThielDH. Lymphoproliferative disorders in chronic hepatitis C. J Viral Hepat2004; 11: 302–9.
44.
NguyenCBKotturiHWarisGMohammedAChandrakesanPMayRSurebanSWeygantNQuDRaoCVDhanasekaranDNBronzeMSHouchenCWAliN. (Z)-3,5,4′-Trimethoxystilbene limits hepatitis C and cancer pathophysiology by blocking microtubule dynamics and cell cycle progression. Cancer Res2016.
45.
SurebanSMMadhounMFMayRQuDAliNFaziliJWeygantNChandrakesanPDingKLightfootSAHouchenCW. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget2015; 6: 37200–15.
46.
MayRQuDWeygantNChandrakesanPAliNLightfootSALiLSurebanSMHouchenCW. Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury. Stem Cells2014; 32: 822–7.
YashiroM. Molecular alterations of colorectal cancer with inflammatory bowel disease. Dig Dis Sci2015; 60: 2251–63.
49.
BarkerN. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol2014; 15: 19–33.
50.
QuDWeygantNMayRChandrakesanPMadhounMAliNSurebanSMAnGSchlosserMJHouchenCW. Ablation of Doublecortin-like Kinase 1 in the colonic epithelium exacerbates dextran sulfate sodium-induced colitis. PLoS One2015; 10: e0134212–e0134212.
51.
WestphalenCBTakemotoYTanakaTMacchiniMJiangZRenzBWChenXOrmannsSNagarKTailorYMayRChoYAsfahaSWorthleyDLHayakawaYUrbanskaAMQuanteMReichertMBroydeJSubramaniamPSRemottiHSuGHRustgiAKFriedmanRAHonigBCalifanoAHouchenCWOliveKPWangTC. Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis. Cell Stem Cell2016; 18: 441–55.
52.
HeerbothSHousmanGLearyMLongacreMBylerSLapinskaKWillbanksASarkarS. EMT and tumor metastasis. Clin Transl Med2015; 4: 6–6.
53.
MendezMGKojimaSGoldmanRD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J2010; 24: 1838–51.
54.
CeramiEGaoJDogrusozUGrossBESumerSOAksoyBAJacobsenAByrneCJHeuerMLLarssonEAntipinYRevaBGoldbergAPSanderCSchultzN. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov2012; 2: 401–4.
55.
GaoJAksoyBADogrusozUDresdnerGGrossBSumerSOSunYJacobsenASinhaRLarssonECeramiESanderCSchultzN. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal2013; 6:. pl1.
56.
SurebanSMMayRLightfootSAHoskinsABLernerMBrackettDJPostierRGRamanujamRMohammedARaoCVWycheJHAnantSHouchenCW. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res2011; 71: 2328–38.
57.
SarrazinCDvory-SobolHSvarovskaiaESDoehleBPangPSChuangSMMaJDingXAfdhalNHKowdleyKVGaneEJLawitzEBrainardDMMcHutchisonJGMillerMDMoH. Prevalence of resistance-associated substitutions in HCV NS5A, NS5B, or NS3 and outcomes of treatment with ledipasvir and sofosbuvir. Gastroenterology2016; 151: 501–12.
58.
ZopfSKremerAENeurathMFSieblerJ. Advances in hepatitis C therapy: what is the current state – what come’s next?World J Hepatol2016; 8: 139–47.
59.
AfdhalNReddyKRNelsonDRLawitzEGordonSCSchiffENahassRGhalibRGitlinNHerringRLalezariJYounesZHPockrosPJDi BisceglieAMAroraSSubramanianGMZhuYDvory-SobolHYangJCPangPSSymondsWTMcHutchisonJGMuirAJSulkowskiMKwoPInvestigatorsION. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med2014; 370: 1483–93.
60.
ContiFBuonfiglioliFScuteriACrespiCBolondiLCaraceniPFoschiFGLenziMMazzellaGVerucchiGAndreonePBrillantiS. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct acting antivirals. J Hepatol2016; 65: 727–33.
61.
BorenaWStrohmaierSLukanovaABjorgeTLindkvistBHallmansGEdlingerMStocksTNagelGManjerJEngelandASelmerRHaggstromCTretliSConcinHJonssonHStattinPUlmerH. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer2012; 131: 193–200.
62.
AliNAllamHBaderTMayRBasalingappaKMBerryWLChandrakesanPQuDWeygantNBronzeMSUmarSJanknechtRSurebanSMHuyckeMHouchenCW. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One2013; 8: e80304–e80304.
63.
SurebanSMMayRWeygantNQuDChandrakesanPBannerman-MensonEAliNPantazisPWestphalenCBWangTCHouchenCW. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Lett2014; 351: 151–61.
64.
WeygantNQuDBerryWLMayRChandrakesanPOwenDBSurebanSMAliNJanknechtRHouchenCW. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer2014; 13: 103–103.
65.
PonnurangamSMammenJMRamalingamSHeZZhangYUmarSSubramaniamDAnantS. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Canc Therapeut2012; 11: 963–72.
66.
SurebanSMMayRRamalingamSSubramaniamDNatarajanGAnantSHouchenCW. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology2009; 137: 649–59. 59 e1–2.
67.
SurebanSMMayRMondalekFGQuDPonnurangamSPantazisPAnantSRamanujamRPHouchenCW. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnol2011; 9: 40–40.
68.
YangQDengXLuBCameronMFearnsCPatricelliMPYatesJR3rdGrayNSLeeJD. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell2010; 18: 258–67.
69.
NagamineTShimomuraSSueyoshiNKameshitaI. Influence of Ser/Pro-rich domain and kinase domain of double cortin-like protein kinase on microtubule-binding activity. J Biochem2011; 149: 619–27.
70.
AtsukawaMTsubotaAKondoCItokawaNNaraharaYNakatsukaKHashimotoSFukudaTMatsushitaYKidokoroHKobayashiTKanazawaHSakamotoC. Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b. J Gastroenterol Hepatol2013; 28: 51–6.
71.
MilazzoLCarammaIMazzaliCCesariMOlivettiMGalliMAntinoriS. Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. J Antimicrob Chemother2010; 65: 735–40.
72.
Selic KurincicTLesnicarGPoljakMMeglic VolkarJRajterMPrahJBaklanZKotarTMaticicM. Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naive chronic hepatitis C Patients infected with genotypes 1 and 3. Intervirology2014; 57: 23–30.
73.
BaderTHughesLDFaziliJFrostBDunnamMGontermanAMadhounMAstonCE. A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype 1 hepatitis C patients. J Viral Hepat2013; 20: 622–7.
74.
JangHJHongEMParkSWByunHWKohDHChoiMHKaeSHLeeJ. Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation. Oncol Lett2016; 12: 250–6.
75.
MouawadCAMradMFEl-AchkarGAAbdul-SaterANemerGMCreminonCLotersztajnSHabibA. Statins modulate cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in human hepatic myofibroblasts. J Cell Biochem2016; 117: 1176–86.
76.
KantaraCO’ConnellMSarkarSMoyaSUllrichRSinghP. Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA. Cancer Res2014; 74: 2487–98.
77.
YangerKKniginDZongYMaggsLGuGAkiyamaHPikarskyEStangerBZ. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell2014; 15: 340–9.
78.
SchaubJRMalatoYGormondCWillenbringH. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep2014; 8: 933–9.
OmoriYSuzukiMOzakiKHaradaYNakamuraYTakahashiEFujiwaraT. Expression and chromosomal localization of KIAA0369, a putative kinase structurally related to Doublecortin. J Hum Genet1998; 43: 169–77.
